Abbott to work on Tarceva diagnostic

March 12, 2008
Sales and Marketing

Abbott is to develop a diagnostic test for Tarceva to identify patients who could most benefit from the lung cancer …

Lilly decision spells end for inhaled insulin

March 12, 2008
Research and Development

Regulatory problems and doubts about commercial potential have led Lilly to abandon its late-stage inhaled insulin product. The AIR insulin …

New laws will oblige pharma to release data

March 7, 2008
Sales and Marketing

The UK government has pledged to introduce new legislation that will require pharmaceutical companies to disclose all data from clinical …

GPs reluctantly agree to extend hours

March 7, 2008

General practitioners across the UK have voted to accept new working hours that will see surgeries open on Saturday mornings …

Efexor successor approved in US

March 7, 2008
Sales and Marketing

Wyeth's Pristiq, a refined version of its top-selling depression treatment Efexor, has been approved in the US. Pristiq (desvenlafaxine) delivers …

Renovo wounded by cosmetic drug setback

March 7, 2008
Research and Development, Sales and Marketing

UK biotech company Renovo has received disappointing clinical trial results for its new anti-scarring and wound healing drug Juvista. The …

Frontline doctor to lead UK diabetes strategy

March 7, 2008

Dr Rowan Hillson has been appointed the new national clinical director for diabetes. Dr Hillson is a consultant physician and …

NICE’s approach to benefits and costs to be reviewed

March 7, 2008
Sales and Marketing

The pharmaceutical industry has welcomed plans to review how NICE assesses the benefits and costs of drugs, with the hope …

Diabetes nurses would cut emergency admissions

March 7, 2008
Sales and Marketing

Specialist nurses could help to cut the number of diabetes patients being admitted to hospital as emergency cases, a new …

Latest news from Datamonitor

March 5, 2008
Sales and Marketing

APP Pharma granted approval for generic anticancer drug APP Pharmaceuticals has received final approval from the FDA of its abbreviated …

Government remains tight-lipped on PPRS

February 29, 2008
Sales and Marketing par

The Department of Health has refused to comment on renewed speculation on the future of the UK's medicines pricing system …

FDA rejects long-acting version of Zyprexa

February 29, 2008
Sales and Marketing

Lilly has suffered a setback after the US medicines regulator rejected a new version of its top-selling product Zyprexa. The …

Working with NICE: the ingredients for success

February 29, 2008
Research and Development, Sales and Marketing NICE, healthcare, industry relations, pharma

NICE fascinates everyone in the industry, and NICE knows only too well that every move it makes is studied by …

Avastin receives surprise FDA approval

February 29, 2008
Sales and Marketing

The FDA gone against the advice of its own advisory panel to approve Genentech's Avastin as a first-line treatment for …

AstraZeneca fined $200m over Medicaid pricing

February 29, 2008
Sales and Marketing

A US court has ruled AstraZeneca must pay more than $200 million for inflating the prices of drugs prescribed under …

Latest news from Datamonitor

February 28, 2008
Sales and Marketing

Algeta to initiate US clinical trials for prostate cancer drug Cancer therapeutics company Algeta has said that it will commence …

The Gateway to Local Adoption Series

Latest content